U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 074530

Expand all

TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
EQ 1MG BASE
Marketing Status: Discontinued
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A074530
Product Number: 001
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status:  Discontinued
Patent and Exclusivity Information
TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
EQ 2MG BASE
Marketing Status: Discontinued
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A074530
Product Number: 002
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status:  Discontinued
Patent and Exclusivity Information
TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
EQ 5MG BASE
Marketing Status: Discontinued
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A074530
Product Number: 003
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status:  Discontinued
Patent and Exclusivity Information
TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
EQ 10MG BASE
Marketing Status: Discontinued
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A074530
Product Number: 004
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top